Arthritis Drug Approved by the US FDA
Arthritis Drug Approved by the US FDA
Filed under: drug treatment news 2012
The U.S. Food and Drug Administration this week approved Xeljanz (tofacitinib) for the treatment of moderate to severe rheumatoid arthritis (RA) in adults who have not responded to methotrexate. The twice-daily pill works by blocking molecules known as …
Read more on WebProNews
Upcoming BioPharma Catalyst Trades to Consider
Filed under: drug treatment news 2012
In July 2012, Ligand's partner GlaxoSmithKline ( GSK ) was granted priority review from the US Food and Drug Administration for the sNDA for Promacta to treat thrombocytopenia in adult patients with chronic hepatitis C virus (HCV) infection. Priority …
Read more on NASDAQ
Good Porn, Bad Porn
Filed under: drug treatment news 2012
“Increased access to the Internet by adolescents has created unprecedented opportunities for sexual education, learning and growth.” (Owens, E. W., Behun, R. J., Manning, J.D. and Reid, R.C. (2012). Journal of Sexual Addiction and Compulsiviy, 19, 99 …
Read more on PsychCentral.com (blog)
Roche Propels Cancer Drug Sales in China With Insurance
Filed under: drug treatment news 2012
Roche Propels Cancer Drug Sales in China With Insurance. By Daryl Loo and Naomi Kresge – 2012-11-13T23:30:50Z. Roche Holding AG (ROG) has found a way to … While that's enough to cover basic treatment, about 13 percent of Chinese households last year …
Read more on Bloomberg